POMC and congenital adrenal hyperplasia: Thirty percent of congenital adrenal hyperplasia (CAH) patients develop PCOS, with ACTH levels > 100 pg/mL conferring a 3.2-fold increased risk, implicating hormonal dysregulation during disease progression [139].